HSPA9 and liver cancer: In the present study, with the addition of the calcium channel inhibitor 2-APB, OA/5FU co-treatment regulated the expressions of Grp75, PDI, and VDAC1, the Ca2+ channel-related proteins, in liver cancer cells.